EA028556B1 - Способ и устройство для контроля экстракорпоральной обработки крови пациента - Google Patents

Способ и устройство для контроля экстракорпоральной обработки крови пациента Download PDF

Info

Publication number
EA028556B1
EA028556B1 EA201492106A EA201492106A EA028556B1 EA 028556 B1 EA028556 B1 EA 028556B1 EA 201492106 A EA201492106 A EA 201492106A EA 201492106 A EA201492106 A EA 201492106A EA 028556 B1 EA028556 B1 EA 028556B1
Authority
EA
Eurasian Patent Office
Prior art keywords
intensity
polarization
anisotropy
fluid
sample
Prior art date
Application number
EA201492106A
Other languages
English (en)
Russian (ru)
Other versions
EA201492106A1 (ru
Inventor
Альфред Гагель
Андреас Майерхофер
Original Assignee
Фрезениус Медикал Кеэ Дойчланд Гмбх
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Фрезениус Медикал Кеэ Дойчланд Гмбх filed Critical Фрезениус Медикал Кеэ Дойчланд Гмбх
Publication of EA201492106A1 publication Critical patent/EA201492106A1/ru
Publication of EA028556B1 publication Critical patent/EA028556B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
    • A61B5/0071—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence by measuring fluorescence emission
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/05—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
    • A61B5/14546—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue for measuring analytes not otherwise provided for, e.g. ions, cytochromes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
    • A61B5/1455—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
    • A61B5/1455—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
    • A61B5/14558—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using optical sensors, e.g. spectral photometrical oximeters by polarisation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/48—Other medical applications
    • A61B5/4836—Diagnosis combined with treatment in closed-loop systems or methods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/48—Other medical applications
    • A61B5/4848—Monitoring or testing the effects of treatment, e.g. of medication
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
    • A61B5/6846—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive
    • A61B5/6847—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive mounted on an invasive device
    • A61B5/6866—Extracorporeal blood circuits, e.g. dialysis circuits
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
    • A61B5/7225—Details of analogue processing, e.g. isolation amplifier, gain or sensitivity adjustment, filtering, baseline or drift compensation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
    • A61M1/1601—Control or regulation
    • A61M1/1603—Regulation parameters
    • A61M1/1605—Physical characteristics of the dialysate fluid
    • A61M1/1609—Physical characteristics of the dialysate fluid after use, i.e. downstream of dialyser
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
    • A61M1/1601—Control or regulation
    • A61M1/1619—Sampled collection of used dialysate, i.e. obviating the need for recovery of whole dialysate quantity for post-dialysis analysis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/28—Peritoneal dialysis ; Other peritoneal treatment, e.g. oxygenation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
    • A61M1/3403—Regulation parameters
    • A61M1/3406—Physical characteristics of the filtrate, e.g. urea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/33—Controlling, regulating or measuring
    • A61M2205/3306—Optical measuring means

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Medical Informatics (AREA)
  • Surgery (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Vascular Medicine (AREA)
  • Anesthesiology (AREA)
  • Optics & Photonics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Signal Processing (AREA)
  • Psychiatry (AREA)
  • Power Engineering (AREA)
  • Artificial Intelligence (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Physiology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • External Artificial Organs (AREA)
  • Investigating Or Analysing Materials By Optical Means (AREA)
EA201492106A 2012-06-15 2013-06-14 Способ и устройство для контроля экстракорпоральной обработки крови пациента EA028556B1 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261660016P 2012-06-15 2012-06-15
EP12172251.6A EP2674103A1 (en) 2012-06-15 2012-06-15 Method and device for monitoring an extracorporeal blood treatment of a patient
PCT/EP2013/062366 WO2013186357A1 (en) 2012-06-15 2013-06-14 Method and device for monitoring an extracorporeal blood treatment of a patient

Publications (2)

Publication Number Publication Date
EA201492106A1 EA201492106A1 (ru) 2015-05-29
EA028556B1 true EA028556B1 (ru) 2017-11-30

Family

ID=46465026

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201492106A EA028556B1 (ru) 2012-06-15 2013-06-14 Способ и устройство для контроля экстракорпоральной обработки крови пациента

Country Status (11)

Country Link
US (1) US10010289B2 (enExample)
EP (2) EP2674103A1 (enExample)
JP (1) JP6242883B2 (enExample)
KR (1) KR102058260B1 (enExample)
CN (1) CN104363820B (enExample)
AU (1) AU2013276453B2 (enExample)
BR (1) BR112014031407B1 (enExample)
CA (1) CA2876542C (enExample)
EA (1) EA028556B1 (enExample)
IN (1) IN2015DN00165A (enExample)
WO (1) WO2013186357A1 (enExample)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9861733B2 (en) 2012-03-23 2018-01-09 Nxstage Medical Inc. Peritoneal dialysis systems, devices, and methods
CA2830085A1 (en) 2011-03-23 2012-09-27 Nxstage Medical, Inc. Peritoneal dialysis systems, devices, and methods
JP6303555B2 (ja) * 2014-02-04 2018-04-04 株式会社ジェイ・エム・エス アルブミン濃度測定装置及びアルブミン濃度測定方法
WO2016057982A1 (en) 2014-10-10 2016-04-14 Nxstage Medical, Inc. Flow balancing devices, methods, and systems
JP6595204B2 (ja) * 2015-04-24 2019-10-23 株式会社島津製作所 光学分析装置
EP3432785B1 (en) * 2016-03-25 2021-03-10 The General Hospital Corporation Polarization-based fluorescent nucleic acid detection
WO2018017623A1 (en) 2016-07-18 2018-01-25 Nxstage Medical, Inc. Flow balancing devices, methods, and systems
EP3506962B1 (en) 2016-08-30 2023-11-22 NxStage Medical, Inc. Parameter monitoring in medical treatment systems
US11826545B2 (en) * 2016-09-08 2023-11-28 Fresenius Medical Care Holdings, Inc. Optical blood detection system
US12048791B2 (en) 2017-06-24 2024-07-30 Nxstage Medical, Inc. Peritoneal dialysis fluid preparation and/or treatment devices methods and systems
DE102017114735B4 (de) * 2017-06-30 2019-07-04 Fresenius Medical Care Deutschland Gmbh Vorrichtung und Verfahren zur Desinfektion
US10948403B2 (en) * 2017-10-06 2021-03-16 Bio-Rad Laboratories, Inc. Protein quantitation device
JP6997582B2 (ja) * 2017-10-17 2022-01-17 日機装株式会社 血液浄化装置
US20190262526A1 (en) 2018-02-28 2019-08-29 Nxstage Medical, Inc. Fluid Preparation and Treatment Devices Methods and Systems
WO2020056808A1 (zh) * 2018-09-21 2020-03-26 北京大学深圳医院 血液中吲哚氰绿的检测装置及系统
WO2020237228A1 (en) 2019-05-23 2020-11-26 Nxstage Medical, Inc. Flow synchronization devices, methods and systems
EP3992617A4 (en) * 2019-06-26 2022-08-17 Asahi Kasei Medical Co., Ltd. Concentration calculation device and blood treatment system
CN110691153B (zh) * 2019-08-27 2020-09-22 珠海格力电器股份有限公司 一种显示模组及终端
US12228564B2 (en) 2020-01-10 2025-02-18 Fresenius Medical Care Holdings, Inc. Systems and methods for analyzing spent dialysate
EP4129356A4 (en) * 2020-03-31 2023-08-23 Asahi Kasei Medical Co., Ltd. BLOOD PURIFICATION SYSTEM, CONTROL METHOD, CONTROL PROGRAM, LEARNING DEVICE AND LEARNING METHOD
US12036344B2 (en) * 2020-11-13 2024-07-16 Fresenius Medical Care Holdings, Inc. Systems and methods for analyzing spent dialysate
DE102021113519A1 (de) * 2021-05-26 2022-12-01 B.Braun Avitum Ag Optischer Sensor zur Bestimmung einer Dialysedosis
JP7754735B2 (ja) * 2022-02-01 2025-10-15 日機装株式会社 透析排液用成分測定装置及び方法
US20240325615A1 (en) 2023-03-31 2024-10-03 Baxter International Inc. System featuring optical and electrical sensors for characterizing effluent from a peritoneal dialysis patient
CN116327188B (zh) * 2023-05-29 2023-09-08 深圳市亿米生命科技有限公司 一种基于指夹式血氧仪的血氧分析方法
CN117250178B (zh) * 2023-09-19 2024-09-13 北京艾锐精仪科技有限公司 一种荧光各向异性探测方法及其探测系统

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5626134A (en) * 1994-04-21 1997-05-06 Zuckerman; Ralph Method and apparatus for the measurement of analyte concentration levels by the steady-state determination of fluorescence lifetime

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4496722A (en) * 1981-05-01 1985-01-29 The Children's Medical Center Corporation Reporter compounds
CA2332833A1 (en) * 1998-05-19 1999-11-25 Spectrx, Inc. Apparatus and method for determining tissue characteristics
JP2002098638A (ja) * 2000-09-26 2002-04-05 Shimadzu Corp 蛍光偏光度測定装置
JP4303125B2 (ja) 2002-01-28 2009-07-29 デビオテック ソシエテ アノニム 腹膜透析システム
US7326576B2 (en) 2003-04-09 2008-02-05 Prescient Medical, Inc. Raman spectroscopic monitoring of hemodialysis
DE102005001051B4 (de) * 2005-01-07 2007-10-31 Fresenius Medical Care Deutschland Gmbh Vorrichtung und Verfahren zur Erkennung von Komplikationen während einer extrakorporalen Blutbehandlung
DE102006029899B4 (de) 2006-06-29 2009-06-04 Fresenius Medical Care Deutschland Gmbh Spektroskopischer Detektor und Verfahren zur Bestimmung von Blut und biologischen Markersubstanzen in Flüssigkeiten
US20080225265A1 (en) * 2007-03-17 2008-09-18 Mi Research, Inc. Method and apparatus for finding macromolecule crystallization conditions
US20110188043A1 (en) * 2007-12-26 2011-08-04 Yissum, Research Development Company of The Hebrew University of Jerusalem, Ltd. Method and apparatus for monitoring processes in living cells
ATE524205T1 (de) 2009-02-11 2011-09-15 Braun B Avitum Ag Vorrichtung zur extrakorporalen blutbehandlung
US20130153474A1 (en) 2010-06-11 2013-06-20 B. Braun Avitum Ag Apparatus for extracorporeal blood treatment, comprising a measuring device for determining the luminescence of the spent dialysate

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5626134A (en) * 1994-04-21 1997-05-06 Zuckerman; Ralph Method and apparatus for the measurement of analyte concentration levels by the steady-state determination of fluorescence lifetime

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
KEISHI YAMASAKI, TORU MARUYAMA, AKIRA TAKADATE, AYAKA SUENAGA, ULRICH KRAGH-HANSEN, MASAKI OTAGIRI: "Characterization of site I of human serum albumin using spectroscopic analyses: Locational relations between regions Ib and Ic of site I", JOURNAL OF PHARMACEUTICAL SCIENCES, AMERICAN CHEMICAL SOCIETY AND AMERICAN PHARMACEUTICAL ASSOCIATION, vol. 93, no. 12, 1 December 2004 (2004-12-01), pages 3004 - 3012, XP002687306, ISSN: 0022-3549, DOI: 10.1002/jps.20203 *
SHAW, A.K. PAL, S.K.: "Resonance energy transfer and ligand binding studies on pH-induced folded states of human serum albumin", JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B: BIOLOGY., ELSEVIER SCIENCE S.A., BASEL., CH, vol. 90, no. 3, 9 January 2008 (2008-01-09), CH, pages 187 - 197, XP022520594, ISSN: 1011-1344, DOI: 10.1016/j.jphotobiol.2008.01.001 *
SMUTZER, G.: "A fluorescent sterol probe study of human serum low-density lipoproteins", BIOCHIMICA ET BIOPHYSICA ACTA - LIPIDS AND LIPID METABOLISM., ELSEVIER SCIENCE BV. AMSTERDAM., NL, vol. 958, no. 3, 19 February 1988 (1988-02-19), NL, pages 323 - 333, XP026042418, ISSN: 0005-2760, DOI: 10.1016/0005-2760(88)90217-2 *

Also Published As

Publication number Publication date
CN104363820A (zh) 2015-02-18
KR102058260B1 (ko) 2019-12-20
EA201492106A1 (ru) 2015-05-29
EP2674103A1 (en) 2013-12-18
JP2015521492A (ja) 2015-07-30
US10010289B2 (en) 2018-07-03
CA2876542C (en) 2020-08-18
US20140046150A1 (en) 2014-02-13
CN104363820B (zh) 2019-07-05
BR112014031407A2 (pt) 2017-06-27
WO2013186357A1 (en) 2013-12-19
KR20150024405A (ko) 2015-03-06
BR112014031407B1 (pt) 2021-12-28
IN2015DN00165A (enExample) 2015-06-12
EP2861127A1 (en) 2015-04-22
CA2876542A1 (en) 2013-12-19
JP6242883B2 (ja) 2017-12-06
EP2861127B1 (en) 2020-09-09
AU2013276453B2 (en) 2017-08-17
AU2013276453A1 (en) 2015-01-22

Similar Documents

Publication Publication Date Title
EA028556B1 (ru) Способ и устройство для контроля экстракорпоральной обработки крови пациента
CN103533972B (zh) 用于监测患者的治疗优选地用于监测血液透析、血液透滤和/或腹膜透析的方法和设备
JP5823389B2 (ja) サンプルにおける検体の存在および／または濃度を決定する方法
US20130153474A1 (en) Apparatus for extracorporeal blood treatment, comprising a measuring device for determining the luminescence of the spent dialysate
JP2007505680A (ja) 血液透析、血液透析濾過、血液濾過または腹膜透析に関わる装置、システムおよび方法
JP7203739B2 (ja) 液体中の血液または血液成分を検出するためのデバイスを校正するための方法およびアセンブリ
EP2577270A1 (en) Method and device for measuring and monitoring concentration of substances in a biological fluid
Uhlin et al. Optical monitoring of dialysis dose
Filutowicz et al. Remarks on spectra-photometric monitoring of urea in dialysate
Uhlin et al. Optical online monitoring of uremic toxins beyond urea
Vasilevski et al. Monitoring the dialysis liquid during hemodialysis from the extinction spectra in the UV region
RU121373U1 (ru) Устройство для мониторинга процесса гемодиализа
Ghanifar et al. Optimal wavelength selection in ultraviolet spectroscopy for the estimation of toxin reduction ratio during hemodialysis
Di Pinto et al. Towards the monitoring of dialysis treatment through absorption and endogenous fluorescence techniques
Vasilevskii et al. Using UV spectrophotometry to analyze peritoneal dialyzate
KR20070018780A (ko) 혈액투석, 혈액투석여과, 혈액여과 또는 복막 투석 관련장치, 시스템 및 방법

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG TJ TM